2004/128/EC: Commission Decision of 23 January 2004 on financial assistance from the Community for the storage of antigens for production of foot-and-mouth disease vaccines in France, Italy and the United Kingdom in 2004 (Text with EEA relevance) (notified under document number C(2004) 102)
Date: 2004-01-23
Institutions: European Commission
Subjects: EU aid, France, Italy, United Kingdom, financial aid, foot-and-mouth disease, storage premium, vaccine

L 37/24

EN

Official Journal of the European Union

10.2.2004

COMMISSION

COMMISSION DECISION

of 23 January 2004

on financial assistance from the Community for the storage of antigens for production of foot-and-
mouth disease vaccines in France, Italy and the United Kingdom in 2004

(notified under document number C(2004) 102)

(Only the French and Italian texts are authentic)

(Text with EEA relevance)

(2004/128/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 14 thereof,

Whereas:

(1)

(2)

(3)

(4)

(5)

In accordance with Council Decision 91/666/EEC of 11
December 1991 establishing Community reserves of
foot-and-mouth disease vaccines (2), the establishment of
antigen banks is part of
the Community's action to
create Community reserves of foot-and-mouth disease
vaccines.

Decision 91/666/EEC designates
the ‘Laboratoire de
pathologie bovine du Centre national d'études vétéri-
naires et alimentaires’ at Lyon in France, which is now
part of the ‘Agence Française de Securité Sanitaire des
Aliments (AFSSA)’, and the ‘Istituto Zooprofilattico Sper-
imentale die Brescia’ in Italy, as antigen banks for the
storage of Community reserves.

Commission Decision 2000/111/EC of December 1999
designating a new antigen bank and making provisions
for the transfer and storage of antigens within the frame-
work of the Community action concerning reserves of
foot-and-mouth disease vaccines (3)
further designates
Merial S.A.S., Pirbright, United Kingdom.

Community assistance should be linked to compliance
with certain conditions as to the functioning of the
antigen banks and the transmission of information and
supporting documents.

For budgetary reasons the Community assistance should
be granted for a period of one year.

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation

(EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1).

(2) OJ L 368, 31.12.1991, p. 21.
(3) OJ L 33, 8.2.2000, p. 19.

(6)

The measures provided for in this Decision are in
accordance with the opinion of the Standing Committee
on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

1.
The Community shall grant financial assistance to Agence
Française de Securité Sanitaire des Aliments for the stocking of
antigens for the production of foot-and-mouth disease vaccines
at the premises of Agence Française de Securité Sanitaire des
Aliments, Lyon.

For the period from 1 January to 31 December 2004 the
2.
maximum amount of financial assistance shall be EUR 30 000.

Article 2

1.
The Community shall grant financial assistance to Istituto
Zooprofilattico Sperimentale di Brescia for the stocking of anti-
gens for the production of foot-and-mouth disease vaccines at
the premises of Istituto Zooprofilattico Sperimentale di Brescia.

2.
For the period from 1 January to 31 December 2004 the
maximum amount of financial assistance shall be EUR 30 000.

Article 3

1.
The Community shall grant financial assistance to Merial
S.A.S. with its headquarters in Lyon, France, for the stocking of
antigens for the production of foot-and-mouth disease vaccines
at the premises of Merial S.A.S., Lyon, France, and at the
premises of Merial S.A.S., Pirbright, United Kingdom.

10.2.2004

EN

Official Journal of the European Union

L 37/25

For the period from 1 January to 31 December 2004 the
2.
maximum amount of financial assistance shall be EUR 81 047.

Article 4

The Community's

financial assistance referred to in
1.
Article 1(2), Article 2(2) and Article 3(2) shall only be granted
if the conditions provided for in Article 4 of Decision 91/666/
EEC are complied with and the information and documents
provided for in paragraph 2 are submitted to the Commission
by 28 February 2005 at the latest.

The information and documents referred to in paragraph

2.
1 shall include the following:

(a) technical information on:

(i) the amount and type of antigen stored (storage

records),

(ii) storage equipment used (type, number and capacity of

tanks),

(iii) security systems in place (temperature control, anti-

theft measures),

(iv) insurance arrangements (fire, accidents);

(b) financial information (completion of a form based on the

model set out in the Annex).

Article 5

This Decision is addressed to the Agence Française de Securité
Sanitaire des Aliments, 31, avenue Tony Garnier, BP 7033, F-
69342 Lyon Cedex 07, France, Istituto Zooprofilattico Speri-
mentale di Brescia, Via Bianchi 9, I-25124 Brescia, Italy, and
Merial S.A.S., 29, avenue Tony Garnier, BP 7123, F-69002
Lyon Cedex 07, France.

Done at Brussels, 23 January 2004.

For the Commission

David BYRNE

Member of the Commission

L 37/26

EN

Official Journal of the European Union

10.2.2004

Financial information related to the storage of antigens for production of foot-and-mouth disease vaccines

ANNEX